Noninvasive prenatal cell-free fetal DNA-based screening for aneuploidies other than trisomy 21
BlueCross BlueShield Association
Record ID 32014001436
English
Authors' objectives:
To determine whether DNA sequencing-based testing for T13, T18, and SCA using cell-free fetal DNA improves net health outcomes compared with a traditional combined serum- and ultrasound-based screening strategy. In the analysis, we presume that a decision to screen for fetal aneuploidy would initially focus on T21 and that downstream events related to T21 screening will hold for screening for T13, T18, or SCA.
Details
Project Status:
Completed
Year Published:
2013
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Humans
- Pregnancy
- Prenatal Diagnosis
- Aneuploidy
- DNA
- Trisomy
Contact
Organisation Name:
BlueCross BlueShield Association
Contact Address:
BlueCross BlueShield Association, Technology Evaluation Center, 225 North Michigan Ave, Chicago, Illinois, USA. Tel: 888 832 4321
Contact Name:
tec@bcbsa.com
Contact Email:
tec@bcbsa.com
Copyright:
BlueCross BlueShield Association (BCBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.